<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="18091">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02871375</url>
  </required_header>
  <id_info>
    <org_study_id>CLE914-P001</org_study_id>
    <nct_id>NCT02871375</nct_id>
  </id_info>
  <brief_title>Clinical Assessment of DAILIES TOTAL1® (DT1) Multifocal</brief_title>
  <official_title>DAILIES TOTAL1® Multifocal Clinical Assessment in Challenging Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alcon, a Novartis Company</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alcon Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate DAILIES TOTAL1 ® Multifocal (DTl MF) contact lenses
      in current multifocal contact lens wearers with symptoms of end of day discomfort compared
      to their habitual multifocal contact lens correction.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2016</start_date>
  <completion_date type="Actual">November 2016</completion_date>
  <primary_completion_date type="Actual">November 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single Blind (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Binocular high contrast/high illumination (HC/HI) visual acuity (VA) at intermediate distance (80 cm)</measure>
    <time_frame>Day 14, each product</time_frame>
    <description>Measured in logarithm minimum angle of resolution (LogMAR)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Contact Lens Dry Eye Questionnaire-8 (CLDEQ-8) score</measure>
    <time_frame>Day 14, each product</time_frame>
    <description>CLDEQ-8 score (assessment of contact lens discomfort) as obtained by adding the numerical responses to each of 8 items (range 0 to 37)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">170</enrollment>
  <condition>Refractive Error</condition>
  <arm_group>
    <arm_group_label>DT1 MF, then Habitual</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Delefilcon A multifocal contact lenses in Period 1, followed by subject's habitual multifocal contact lenses in Period 2. Each product worn bilaterally (in both eyes) for 14 ± 3 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Habitual, then DT1 MF</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Subject's habitual multifocal contact lenses in Period 1, followed by delefilcon A multifocal contact lenses in Period 2. Each product worn bilaterally (in both eyes) for 14 ± 3 days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Delefilcon A multifocal contact lenses</intervention_name>
    <description>Multifocal contact lenses worn in a daily wear, daily disposable modality (new pair of lenses each morning)</description>
    <arm_group_label>DT1 MF, then Habitual</arm_group_label>
    <arm_group_label>Habitual, then DT1 MF</arm_group_label>
    <other_name>DAILIES TOTAL1® multifocal</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Habitual multifocal contact lenses</intervention_name>
    <description>Multifocal contact lenses worn per subject's habitual prescription and habitual daily wear modality</description>
    <arm_group_label>DT1 MF, then Habitual</arm_group_label>
    <arm_group_label>Habitual, then DT1 MF</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Must sign an informed consent document;

          -  Current daily wearer of soft multifocal contact lenses for at least 6 months with
             symptoms of contact lens discomfort as defined by the prescreening Eligibility
             Questionnaire;

          -  Requires a near spectacle add of +0.50 to +2.50 diopters (D) (inclusive);

          -  Requires lenses within the power range of study lenses to be fitted;

          -  Best corrected VA (BCVA) of 20/30 (0.2 logarithmic minimum angle of resolution
             [logMAR]) or better in each eye at distance;

          -  Willing to wear study lenses for a minimum of 5 days per week, 6 hours per day, and
             attend all study visits;

          -  Other protocol-defined inclusion criteria may apply.

        Exclusion Criteria:

          -  Any eye condition that contraindicates wearing contact lenses as determined by the
             Investigator;

          -  Any use of medications for which contact lens wear could be contraindicated, as
             determined by the Investigator;

          -  Monocular (only one eye functional) or fit with only 1 lens;

          -  Fitted with monovision;

          -  Prior refractive surgery (e.g., laser vision correction, photorefractive keratectomy,
             etc.);

          -  History of herpetic keratitis, ocular surgery, or irregular cornea;

          -  Currently wearing DT1 MF contact lenses;

          -  Other protocol-defined exclusion criteria may apply.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Clinical Project Manager, PLS</last_name>
    <role>Study Director</role>
    <affiliation>Alcon, A Novartis Division</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Contact Alcon Center for Trial Locations</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76134</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <lastchanged_date>November 25, 2016</lastchanged_date>
  <firstreceived_date>August 15, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>myopia</keyword>
  <keyword>presbyopia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Refractive Errors</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
